Edwards Lifesciences Corporation (EW) vs IQVIA Holdings Inc. (IQV)
EW and IQV are evenly matched — 8 metrics each of 16.
A side-by-side comparison of Edwards Lifesciences Corporation and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 9, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
EW
Edwards Lifesciences Corporation
$91.33Healthcare
IQV
IQVIA Holdings Inc.
$208.97Healthcare
Total return — EW vs IQV
growth of $100 · last 13yEW +758.4%IQV +383.9%EW compounded faster
EW IQV
EW vs IQV: by the numbers
- •EW is the larger company ($52.59B vs $34.88B market cap).
- •IQV trades at the lower earnings multiple (25.25 vs 49.81 P/E).
- •EW converts more revenue to profit (17.34% vs 8.33% net margin).
- •EW grew revenue faster over the past five years (7.10% vs 6.72% CAGR).
Which is better, EW or IQV?
Metric tally: EW 8 · IQV 8It depends on what you're optimizing for:
ValueIQV(lower P/E)
GrowthEW(faster 5Y revenue CAGR)
QualityEW(higher ROIC)
Metrics side by side
Valuation
| Metric | EW | IQV |
|---|---|---|
| P/E ratio | 49.81 | 25.25● |
| Forward P/E | 31.10 | 15.90● |
| P/S ratio | 8.63 | 2.08● |
| P/B ratio | 5.27● | 5.56 |
| PEG ratio | 7.25 | 6.34● |
| EV / EBITDA | 27.67 | 14.03● |
| FCF yield | 2.00% | 7.35%● |
Profitability
| Metric | EW | IQV |
|---|---|---|
| Gross margin | 78.01%● | 26.11% |
| Operating margin | 27.62%● | 13.86% |
| Net margin | 17.34%● | 8.33% |
| ROE | 10.58% | 22.26%● |
| ROIC | 11.40%● | 8.23% |
Growth (annualized)
| Metric | EW | IQV |
|---|---|---|
| Revenue CAGR (5Y) | 7.10%● | 6.72% |
| EPS CAGR (5Y) | 6.87% | 40.21%● |
| FCF CAGR (5Y) | 8.74%● | 4.53% |
| Total return CAGR (5Y) | -2.85%● | -3.91% |
Frequently asked
- Which is better, EW or IQV?
- It depends on your goal. value: IQV (lower P/E); growth: EW (faster 5Y revenue CAGR); quality: EW (higher ROIC). Across all compared metrics, they are evenly matched.
- Is EW or IQV cheaper?
- On trailing earnings, IQV is cheaper: EW trades at a 49.81 P/E and IQV at 25.25.
- Which has grown faster, EW or IQV?
- Over the past five years, EW grew revenue faster — EW at a 7.10% CAGR versus IQV at 6.72%.
- Is EW or IQV more profitable?
- EW runs the higher net margin — EW at 17.34% versus IQV at 8.33%.
- Which has been the better investment, EW or IQV?
- Over the past 10-year, IQV delivered the higher annualized total return — EW at 10.37% versus IQV at 11.06%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Edwards Lifesciences P/E ratioIQVIA P/E ratioEdwards Lifesciences dividend yieldIQVIA dividend yieldEdwards Lifesciences ROEIQVIA ROEEdwards Lifesciences operating marginIQVIA operating marginEdwards Lifesciences revenue growthIQVIA revenue growthEdwards Lifesciences free cash flowIQVIA free cash flow
Edwards Lifesciences & IQVIA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 9, 2026.